Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition
Authors:
- ENIGMA consortiumECENIGMA consortium
- S. M. CaputoSCS. M. Caputo
- P. K. RoganPRP. K. Rogan
- E. J. MucakiEME. J. Mucaki
- L. J. BurkeLBL. J. Burke
- I. BiècheIBI. Bièche
- 13 December 2017
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 168 (2) , 311-325
Abstract
The molecular mechanism of breast and/or ovarian cancer susceptibility remains unclear in the majority of patients. While germline mutations in the regulatory non-coding regions of BRCA1 and BRCA2 genes have been described, screening has generally been limited to coding regions. The aim of this study was to evaluate the contribution of BRCA1/2 non-coding variants.Keywords
Funding Information
- CEST Curie –This work was supported by French National Cancer Institute (INCa) (PRT-K14-134 to E. SdS)
This publication has 39 references indexed in Scilit:
- BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic StrategyClinical Cancer Research, 2012
- Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancerHuman Molecular Genetics, 2012
- Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databasesNucleic Acids Research, 2011
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesHuman Mutation, 2011
- Detection of nonneutral substitution rates on mammalian phylogeniesGenome Research, 2009
- Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 geneProceedings of the National Academy of Sciences, 2008
- DNA methylation analysis by pyrosequencingNature Protocols, 2007
- Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast CancerJAMA, 2006
- Distinct transcription start sites generate two forms of BRCA1 mRNAHuman Molecular Genetics, 1995
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995